The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Molecular Point-of-Care Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Molecular Point-of-Care Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1741833

No of Pages : 104

Ask Your Query
Synopsis
The global Molecular Point-of-Care Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Molecular point-of-care (POC) testing is a type of diagnostic testing that uses nucleic acid amplification techniques such as polymerase chain reaction (PCR) to rapidly detect the presence of specific genetic material, such as DNA or RNA, directly in patient samples.
This report is a detailed and comprehensive analysis for global Molecular Point-of-Care Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Molecular Point-of-Care Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Molecular Point-of-Care Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Molecular Point-of-Care Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Molecular Point-of-Care Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Point-of-Care Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Point-of-Care Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Molecular Diagnostics, Salignostics, Saw Diagnostics, Siemens Healthineer and Sona Nanotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Molecular Point-of-Care Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polymerase Chain Reaction (PCR)
Loop-mediated Isothermal Amplification (LAMP)
Nucleic Acid Sequence-based Amplification (NASBA)
Market segment by Application
Infectious Diseases
Genetic Disorders
Pregnancy Testing
Diagnosis of Cancer
Pharmacogenomics
Market segment by players, this report covers
Roche Molecular Diagnostics
Salignostics
Saw Diagnostics
Siemens Healthineer
Sona Nanotech
T2 Biosystems
Talis Biomedical
Thermo Fisher Scientific Inc.
Veramarx
XCR Diagnostics
Zhejiang Orient Gene Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Molecular Point-of-Care Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Point-of-Care Testing, with revenue, gross margin and global market share of Molecular Point-of-Care Testing from 2018 to 2023.
Chapter 3, the Molecular Point-of-Care Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Molecular Point-of-Care Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Point-of-Care Testing.
Chapter 13, to describe Molecular Point-of-Care Testing research findings and conclusion.
Index
1 Market Overview
1.1 Product Overview and Scope of Molecular Point-of-Care Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Molecular Point-of-Care Testing by Type
1.3.1 Overview: Global Molecular Point-of-Care Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Molecular Point-of-Care Testing Consumption Value Market Share by Type in 2022
1.3.3 Polymerase Chain Reaction (PCR)
1.3.4 Loop-mediated Isothermal Amplification (LAMP)
1.3.5 Nucleic Acid Sequence-based Amplification (NASBA)
1.4 Global Molecular Point-of-Care Testing Market by Application
1.4.1 Overview: Global Molecular Point-of-Care Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Infectious Diseases
1.4.3 Genetic Disorders
1.4.4 Pregnancy Testing
1.4.5 Diagnosis of Cancer
1.4.6 Pharmacogenomics
1.5 Global Molecular Point-of-Care Testing Market Size & Forecast
1.6 Global Molecular Point-of-Care Testing Market Size and Forecast by Region
1.6.1 Global Molecular Point-of-Care Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Molecular Point-of-Care Testing Market Size by Region, (2018-2029)
1.6.3 North America Molecular Point-of-Care Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Molecular Point-of-Care Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Molecular Point-of-Care Testing Market Size and Prospect (2018-2029)
1.6.6 South America Molecular Point-of-Care Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Molecular Point-of-Care Testing Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Roche Molecular Diagnostics
2.1.1 Roche Molecular Diagnostics Details
2.1.2 Roche Molecular Diagnostics Major Business
2.1.3 Roche Molecular Diagnostics Molecular Point-of-Care Testing Product and Solutions
2.1.4 Roche Molecular Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Molecular Diagnostics Recent Developments and Future Plans
2.2 Salignostics
2.2.1 Salignostics Details
2.2.2 Salignostics Major Business
2.2.3 Salignostics Molecular Point-of-Care Testing Product and Solutions
2.2.4 Salignostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Salignostics Recent Developments and Future Plans
2.3 Saw Diagnostics
2.3.1 Saw Diagnostics Details
2.3.2 Saw Diagnostics Major Business
2.3.3 Saw Diagnostics Molecular Point-of-Care Testing Product and Solutions
2.3.4 Saw Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Saw Diagnostics Recent Developments and Future Plans
2.4 Siemens Healthineer
2.4.1 Siemens Healthineer Details
2.4.2 Siemens Healthineer Major Business
2.4.3 Siemens Healthineer Molecular Point-of-Care Testing Product and Solutions
2.4.4 Siemens Healthineer Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Siemens Healthineer Recent Developments and Future Plans
2.5 Sona Nanotech
2.5.1 Sona Nanotech Details
2.5.2 Sona Nanotech Major Business
2.5.3 Sona Nanotech Molecular Point-of-Care Testing Product and Solutions
2.5.4 Sona Nanotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sona Nanotech Recent Developments and Future Plans
2.6 T2 Biosystems
2.6.1 T2 Biosystems Details
2.6.2 T2 Biosystems Major Business
2.6.3 T2 Biosystems Molecular Point-of-Care Testing Product and Solutions
2.6.4 T2 Biosystems Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 T2 Biosystems Recent Developments and Future Plans
2.7 Talis Biomedical
2.7.1 Talis Biomedical Details
2.7.2 Talis Biomedical Major Business
2.7.3 Talis Biomedical Molecular Point-of-Care Testing Product and Solutions
2.7.4 Talis Biomedical Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Talis Biomedical Recent Developments and Future Plans
2.8 Thermo Fisher Scientific Inc.
2.8.1 Thermo Fisher Scientific Inc. Details
2.8.2 Thermo Fisher Scientific Inc. Major Business
2.8.3 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product and Solutions
2.8.4 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.9 Veramarx
2.9.1 Veramarx Details
2.9.2 Veramarx Major Business
2.9.3 Veramarx Molecular Point-of-Care Testing Product and Solutions
2.9.4 Veramarx Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Veramarx Recent Developments and Future Plans
2.10 XCR Diagnostics
2.10.1 XCR Diagnostics Details
2.10.2 XCR Diagnostics Major Business
2.10.3 XCR Diagnostics Molecular Point-of-Care Testing Product and Solutions
2.10.4 XCR Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 XCR Diagnostics Recent Developments and Future Plans
2.11 Zhejiang Orient Gene Biotech
2.11.1 Zhejiang Orient Gene Biotech Details
2.11.2 Zhejiang Orient Gene Biotech Major Business
2.11.3 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product and Solutions
2.11.4 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zhejiang Orient Gene Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Molecular Point-of-Care Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Molecular Point-of-Care Testing by Company Revenue
3.2.2 Top 3 Molecular Point-of-Care Testing Players Market Share in 2022
3.2.3 Top 6 Molecular Point-of-Care Testing Players Market Share in 2022
3.3 Molecular Point-of-Care Testing Market: Overall Company Footprint Analysis
3.3.1 Molecular Point-of-Care Testing Market: Region Footprint
3.3.2 Molecular Point-of-Care Testing Market: Company Product Type Footprint
3.3.3 Molecular Point-of-Care Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Molecular Point-of-Care Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Molecular Point-of-Care Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Molecular Point-of-Care Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Molecular Point-of-Care Testing Market Forecast by Application (2024-2029)
6 North America
6.1 North America Molecular Point-of-Care Testing Consumption Value by Type (2018-2029)
6.2 North America Molecular Point-of-Care Testing Consumption Value by Application (2018-2029)
6.3 North America Molecular Point-of-Care Testing Market Size by Country
6.3.1 North America Molecular Point-of-Care Testing Consumption Value by Country (2018-2029)
6.3.2 United States Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Molecular Point-of-Care Testing Consumption Value by Type (2018-2029)
7.2 Europe Molecular Point-of-Care Testing Consumption Value by Application (2018-2029)
7.3 Europe Molecular Point-of-Care Testing Market Size by Country
7.3.1 Europe Molecular Point-of-Care Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
7.3.3 France Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Molecular Point-of-Care Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Molecular Point-of-Care Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Molecular Point-of-Care Testing Market Size by Region
8.3.1 Asia-Pacific Molecular Point-of-Care Testing Consumption Value by Region (2018-2029)
8.3.2 China Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
8.3.5 India Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
9 South America
9.1 South America Molecular Point-of-Care Testing Consumption Value by Type (2018-2029)
9.2 South America Molecular Point-of-Care Testing Consumption Value by Application (2018-2029)
9.3 South America Molecular Point-of-Care Testing Market Size by Country
9.3.1 South America Molecular Point-of-Care Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Molecular Point-of-Care Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Molecular Point-of-Care Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Molecular Point-of-Care Testing Market Size by Country
10.3.1 Middle East & Africa Molecular Point-of-Care Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Molecular Point-of-Care Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Molecular Point-of-Care Testing Market Drivers
11.2 Molecular Point-of-Care Testing Market Restraints
11.3 Molecular Point-of-Care Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Molecular Point-of-Care Testing Industry Chain
12.2 Molecular Point-of-Care Testing Upstream Analysis
12.3 Molecular Point-of-Care Testing Midstream Analysis
12.4 Molecular Point-of-Care Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock